DTC Comparative Drug Campaigns To Be Addressed At FDA Public Meeting

Standards for comparative drug claims in direct-to-consumer ads will be one topic for discussion during a Sept. 22-23 FDA public meeting on consumer-directed promotion of prescription drugs